- Home
- » Tags
- » Doxifluridine
Top View
- Supplement 1A. Antineoplastic Medications Samples of the Intervention Group
- (51) International Patent Classification: A61K 47/64 (20 .0 ) (21
- Gastric Cancer Drug Trials—Are Women Second Class Citizens? Lishi Wang, Yan Jiao, Yun Jiao, Yanhong Cao and Weikuan Gu
- Pharmaceutical Compositions and Dosage Forms of Thalidomide
- Poison Or Antibiotic? a Guide to "Class" Entries
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- List of Cancer Drugs (The First Batch) Ⅰ.Cancer Drugs
- United States Patent $835 a 88: As: Inhibitor 1-((R)-3-(4-Amino-3-(4
- 2605.Full-Text.Pdf
- The Oral Fluoropyrimidines in Cancer Chemotherapy
- Overview of Evidence-Based Chemotherapy for Oralcancer
- PROTOCOLO CIBOMA V3 Ingles
- An Open, Multi-Centre, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Paclitaxel, UFT, and Leucovorin in Patients with Advanced Gastric Cancer
- Wo 2007/044693 A2
- Roche Annual Report 2012
- Potentiation of High Linear Energy Transfer Radiation with Paclitaxel for the Treatment of Disseminated Peritoneal Disease Diane E
- Molecular Blueprints for Antitumor Drugs
- Production of Reactive Oxygen Species and Nitric Oxide by Anticancer Agents in Rat Polymorphonuclear Leukocytes
- Distribution of Anticancer Drugs in River Waters and Sediments of the Yodo River Basin, Japan
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- 위암의 근치적 절제술 후 Doxifluridine, Cisplatin 보조적 복합화학요법의 효능에 대한 후향적 연구
- Comparative Effects of the Administration Period of Adjuvant
- WO 2U11/132171 Al
- Pharmaceutical Appendix to the Tariff Schedule 2
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Download.Html (Accessed on 23 February 2021)
- Chemotherapy for Advanced Gastric Cancer: Review and Update of Current Practices
- Pharmaceuticals Appendix
- Solid Forms of 3-(5-Amino-2-Methyl-4-Oxo-4H
- A Combination Phase I Study of Weekly Paclitaxel and Doxifluridine in Advanced Gastric Cancer Patients
- (12) United States Patent (10) Patent No.: US 7,727,968 B2 Feingold Et Al